Serum 5′-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease

Serum 5′-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease

Background: The correlation between 5′-Nucleotidase (5′-NT) and the clinical outcomes in coronary artery disease (CAD) patients following percutaneous coronary intervention (PCI) is not clear. This study aims to clarify this relationship. Methods: The PRACTICE study enrolled 15,250 patients between...

Full description

Bibliographic Details
Main Authors: Mikereyi Aimaitijiang, Ting-Ting Wu, Ying-Ying Zheng, Xian-Geng Hou, Haitao Yang, Yi Yang, Xiang Xie
Format: Article
Language:English
Published: IMR Press 2024-01-01
Series:Reviews in Cardiovascular Medicine
Subjects:
5′-nucleotidase (5′-nt)
coronary artery disease (cad)
cd73
prognosis
Online Access:https://www.imrpress.com/journal/RCM/25/1/10.31083/j.rcm2501017

Internet

https://www.imrpress.com/journal/RCM/25/1/10.31083/j.rcm2501017

Similar Items